Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2900-2901

  Ceccarelli, Giancarlo ^a   Falcone, Marco ^b   Giordano, Alessandra ^a   Mezzatesta, Maria Lina ^c   Caio, Carla ^c   Stefani, Stefania ^c   Venditti, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; COLISTIN; CREATININE; DORIPENEM; ERTAPENEM; FOSFOMYCIN; MEROPENEM; PROCALCITONIN; RIFAMPICIN;

AGED; ANTIBIOTIC THERAPY; BROTH DILUTION; CASE REPORT; FEVER; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; THROMBOCYTE; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMS; CARBAPENEMS; COLISTIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME;

EID: 84877847319     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00188-13     Document Type: Letter

References (11)

1. Orsi GB, Falcone M, Venditti M. 2011. Surveillance and management of multidrug-resistant microrganisms. Expert Rev. Anti Infect. Ther. 9:653-679.
2. Orsi GB, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, Giordano A, Venditti M. 2013. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: Results of a double case-control study. Infection 41:61-67.
3. Orsi GB, Garcia-Fernandez A, Giordano A, Venditti C, Bencardino A, Gianfreda R, Falcone M, Carattoli A, Venditti M. 2011. Risk factors for and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J. Hosp. Infect. 78:54-58.
4. Pournaras S, Vrioni G, Neou E, Dendrinos J, Dimitroulia E, Poulou A, Tsakris A. 2011. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Int. J. Antimicrob. Agents 37:244-247.
5. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. 2012. Predictors of mortality in bloodstream infections caused by Klebsiella pneumonia carbapenemaseproducing K. pneumoniae: Importance of combination therapy. Clin. Infect. Dis. 55:943-950.
6. Sbrana F, Malacarne P, Viaggi B, Costanzo S, Leonetti P, Leonildi A, Casini B, Tascini C, Menichetti F. 2013. Carbapenem-sparing antibiotic regimens for infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae in intensive care unit. Clin. Infect. Dis. 56:697-700.
7. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N; on behalf of the SEERBIO-GRAB network. 2013. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin. Microbiol. Infect. 19:E23-E30.
8. Karageorgopoulos DE, Wang R, Yu XH, Falagas ME. 2012. Fosfomycin: Evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J. Antimicrob. Chemother. 67: 255-268.
9. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18: 268-281.
10. European Committee on Antimicrobial Susceptibility Testing. 2013. Breakpoint tables for interpretation of MICs and zone diameters, version 3.0.EUCAST, Växjö, Sweden. 11. Mezzatesta ML, Gona F, Caio C, Petrolito V, Sciortino D, Sciacca A, Santangelo C, Stefani S. 2011. Outbreak of KPC-3-producing, and colistin resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin. Microbiol. Infect. 17:1444-1447.
11. Bulik CC, Nicolau DP. 2011. Double-carbapenem therapy for carbapenemase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 55:3002-3004.